Replimune Group, Inc. (REPL) Misses Q4 EPS by 235c
Tweet
Share
E-mailGet Alerts REPL Hot Sheet
Join SI Premium – FREE
Replimune Group, Inc. (NASDAQ: REPL) reported Q4 EPS of ($3.07), $2.35 worse than the analyst estimate of ($0.72).
For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Trump highlights ibogaine development push, Psyence BioMed responds
- AXIL Brands (AXIL) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
